Not checkedNot checked for notices yet.
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma
Li Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong and 21 more
Nature Communications · 2020
doi:10.1038/s41467-020-15318-5 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The MET receptor is frequently activated in cancer. Here, the authors show that in head and neck and lung squamous carcinoma, a polymorphic MET variant enhances binding to HER2, resulting in activation of HER2 signalling and progression of the cancers.
Abstract licence: CC BY-NC-ND
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.